Antiblastic chemotherapy for haematologic malignancies and second tumours

被引：0
|
作者：
Barillari, G [1 ]
Zaja, F [1 ]
Baccarani, M [1 ]
机构：
[1] UNIV HOSP,DEPT BONE MARROW TRANSPLANT,UDINE,ITALY
来源：
EUROPEAN JOURNAL OF CANCER PREVENTION | 1996年 / 5卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：402 / 404
页数：3
相关论文
共 50 条
  • [1] LOCAL ANTIBLASTIC CHEMOTHERAPY IN TUMOURS OF BLADDER
    CURRO, S
    PANMINERVA MEDICA, 1973, 15 (09) : 298 - &
  • [2] Standardisation of pathogenicity classification for somatic alterations in solid tumours and haematologic malignancies
    Koeppel, Florence
    Muller, Etienne
    Harle, Alexandre
    Guien, Celine
    Sujobert, Pierre
    Grati, Olfa Trabelsi
    Kosmider, Olivier
    Miguet, Laurent
    Mauvieux, Laurent
    Cayre, Anne
    Salgado, David
    Preudhomme, Claude
    Karayan-Tapon, Lucie
    Tachon, Gaelle
    Coulet, Florence
    Lespagnol, Alexandra
    Beroud, Christophe
    Leroy, Karen
    Rouleau, Etienne
    Soubeyran, Isabelle
    EUROPEAN JOURNAL OF CANCER, 2021, 159 : 1 - 15
  • [3] Topotecan in haematologic malignancies
    Weihrauch, MR
    Tesch, H
    ONKOLOGIE, 1998, 21 : 28 - 31
  • [4] Factors influencing mortality in neutropenic patients with haematologic malignancies or solid tumours with bloodstream infection
    Marin, M.
    Gudiol, C.
    Ardanuy, C.
    Garcia-Vidal, C.
    Jimenez, L.
    Domingo-Domenech, E.
    Perez, F. J.
    Carratala, J.
    CLINICAL MICROBIOLOGY AND INFECTION, 2015, 21 (06) : 583 - 590
  • [5] Multicentre retrospective analysis of second allogeneic HSCT outcomes for haematologic malignancies in Korea
    Kim, K. H.
    Jung, C. W.
    Jang, J. H.
    Kim, K.
    Ahn, H. K.
    Won, J. H.
    Hong, D. S.
    Moon, J. H.
    Sohn, S. K.
    Kim, Y. K.
    Yang, D. H.
    Lee, J. J.
    Kim, H. J.
    Kim, J. S.
    Min, Y. H.
    Kim, D. Y.
    Lee, J. H.
    Lee, J. H.
    Lee, K. H.
    Kim, I.
    Yoon, S. S.
    Park, S.
    Lee, S. M.
    Joo, Y. D.
    Jun, H. J.
    Kim, D. H.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S114 - S114
  • [6] Management of haematologic malignancies in pregnancy
    Wong, GC
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2002, 31 (03) : 303 - 310
  • [7] Incidence of Second Primary Malignancies in Patients with Neuroendocrine Tumours
    Clift, Ashley K.
    Drymousis, Panagiotis
    Al-Nahhas, Adil
    Wasan, Harpreet
    Martin, John
    Holm, Sture
    Frilling, Andrea
    NEUROENDOCRINOLOGY, 2015, 102 (1-2) : 26 - 32
  • [8] Invasive pulmonary aspergillosis: comparative analysis in cancer patients with underlying haematologic malignancies versus solid tumours
    Dib, R. W.
    Khalil, M.
    Fares, J.
    Hachem, R. Y.
    Jiang, Y.
    Dandachi, D.
    Chaftari, A-M
    Raad, I. I.
    JOURNAL OF HOSPITAL INFECTION, 2020, 104 (03) : 358 - 364
  • [9] Second primary tumours (SPTs) after chemotherapy
    Cartei, G
    Liquori, S
    Tabaro, G
    Cartei, F
    EUROPEAN JOURNAL OF CANCER PREVENTION, 1996, 5 (05) : 400 - 402
  • [10] Haematologic toxicity in dogs with mast cell tumours treated with vinblastine/prednisolone chemotherapy with/without radiotherapy
    Stiborova, K.
    Treggiari, E.
    Amores-Fuster, I
    del Busto, I
    Killick, D.
    Maddox, T.
    Marrington, M.
    Mason, S. L.
    Blackwood, L.
    JOURNAL OF SMALL ANIMAL PRACTICE, 2019, 60 (09) : 534 - 542
12345